TRCT
GNPX icon

Tower Research Capital (TRC)’s Genprex GNPX Stock Holding History

Tower Research Capital (TRC)’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Buy
+129
New +$2.48K ﹤0.01% 4810
2026
Q1 		– Sell
-149
Closed -$5.74K – 5281
2025
Q4 		$5.74K Buy
149
+144
+2,880% +$20.3K ﹤0.01% 4099
2025
Q3 		$984 Hold
5
– – ﹤0.01% 4896
2025
Q2 		$1.36K Hold
5
– – ﹤0.01% 4822
2025
Q1 		$1.39K Hold
5
– – ﹤0.01% 4719
2024
Q4 		$5.1K Sell
5
-3
-38% -$3.93K ﹤0.01% 4351
2024
Q3 		$3.35K Buy
8
+4
+100% +$4.94K ﹤0.01% 4862
2024
Q2 		$7.34K Buy
4
+1
+33% +$2.69K ﹤0.01% 4474
2024
Q1 		$8.24K Buy
+3
New +$19.7K ﹤0.01% 4057
2023
Q4 		– Hold
0
– – – 5104
2023
Q3 		– Hold
0
– -$9.71K – 6042
2023
Q2 		– Hold
0
– – – 4231
2023
Q1 		– Hold
0
– – – 4490
2022
Q4 		– Hold
0
– – – 3711
2022
Q3 		– Hold
0
– – – 3600
2022
Q2 		– Hold
0
– – – 5542
2022
Q1 		– Hold
0
– – – 3625
2021
Q4 		– Hold
0
– – – 3846
2021
Q3 		– Hold
0
– – – 3559
2021
Q2 		– Hold
0
– -$46K – 5608
2021
Q1 		– Hold
0
– – – 3193
2020
Q4 		– Sell
-1
Closed -$155K – 3719
2020
Q3 		$93K Buy
+1
New +$158K ﹤0.01% 3197
2020
Q2 		– Hold
0
– – – 4338

Other funds holding GNPX

Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EGM
Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
CVM
Cheviot Value Management Beverly Hills, California $984M AUM 24.46% 1-Year Est. Return

Tower Research Capital (TRC)'s GNPX Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Genprex (GNPX) in Q2 2026: 129 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #4810 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in GNPX as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in GNPX in Q3 2020 and has held it in 10 quarters since. The position peaked at $93K in Q3 2020. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • Tower Research Capital (TRC) held 129 shares of Genprex worth $1.48K as of Q2 2026.
  • Genprex was a new Tower Research Capital (TRC) position in Q2 2026.
  • Genprex made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4810 holding.
  • Tower Research Capital (TRC) first reported a position in Genprex in Q3 2020 and has held it in 10 quarters since.
  • Tower Research Capital (TRC)'s Genprex position peaked at $93K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.